Back to Results
First PageMeta Content
Epidemiology / Medical statistics / Clinical research / Design of experiments / Imiquimod / Actinic keratosis / Squamous-cell carcinoma / Clinical trial / Cutaneous leishmaniasis / Medicine / Health / Pharmacology


Microsoft WordIngenol PICATO LEO PharmaPSD FINAL.doc
Add to Reading List

Document Date: 2014-10-01 21:56:22

Open Document

File Size: 94,16 KB

Share Result on Facebook

City

Trial / /

Company

LEO Pharma Pty Ltd / /

Country

Australia / /

Currency

USD / /

Event

FDA Phase / /

IndustryTerm

treatment algorithm / /

MedicalCondition

inflammatory response / keratoses / Actinic Keratosis / clinically evident solar keratosis / solar keratoses / squamous cell carcinoma / Treat Actinic Keratoses / solar keratosis / actinic keratoses / /

Organization

American Academy of Dermatology / Listing Requested and PBAC’s View Authority / /

Person

Ingenol / /

Position

representative / Trial ID/ First Protocol title/ Publication title author / /

Product

fluorouracil / SK Ingenol / PEP0055 / PEP005 / SK / PEP005-015 / PEP00559 / /

ProvinceOrState

Saskatchewan / /

PublishedMedium

Archives of Dermatology / British Journal of Dermatology / /

Technology

treatment algorithm / /

SocialTag